Terminalcare Support Institute Inc. (7362.T)
JPY 910.0
(-0.44%)
JPY 910.0
(-0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 238.18 Million | 812.73 Million | 462.18 Million | 124.89 Million | 192.1 Million |
| Net Income | 192.64 Million | 246.5 Million | 187.63 Million | 134.3 Million | 76 Million |
| Depreciation & Amortization | 86.28 Million | 69.11 Million | 75 Million | 79.36 Million | 61.81 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 147.32 Million | 557.83 Million | 196.06 Million | -93.5 Million | 24.01 Million |
| Other non-cash items | -150.59 Million | -40.15 Million | 28.17 Million | 13.8 Million | -76 Million |
| Investing Cash Flow | -836.32 Million | -510.68 Million | -523.54 Million | -74.57 Million | -360.65 Million |
| Investments in PPE | -835.61 Million | -509.68 Million | -519.46 Million | -73.37 Million | -364.68 Million |
| Acquisitions | - | - | - | - | 5.22 Million |
| Investment purchases | -1.2 Million | -1.2 Million | -1.2 Million | -1.2 Million | -1.2 Million |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 486 Thousand | 202 Thousand | -2.88 Million | -1000.00 | - |
| Financing Cash Flow | 892.45 Million | -90.11 Million | 523.02 Million | -56.63 Million | 317.64 Million |
| Debt repayment | -920.45 Million | -85.72 Million | -2.18 Million | -47.11 Million | -317.64 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -27.99 Million | -128 Thousand | - | - | - |
| Common Stock Issuance | - | - | 552 Million | - | - |
| Other Financing Activities | -1000.00 | 145 Million | -1.79 Million | -3.73 Million | -9.47 Million |
| Accounts receivables | -83 Million | 26 Million | -98 Million | -46 Million | -31.42 Million |
| Accounts payables | 33.34 Million | -15.59 Million | 18.84 Million | -21.19 Million | 15.45 Million |
| Inventory | 175.41 Million | 525.9 Million | 257.07 Million | 52.12 Million | -769 Thousand |
| Other working capital | -150 Million | -39 Million | 23 Million | -88 Million | 40.75 Million |
| Cash at beginning of period | 1.07 Billion | 865.11 Million | 403.44 Million | 409.76 Million | 260.67 Million |
| Cash at end of period | 1.37 Billion | 1.07 Billion | 865.11 Million | 403.44 Million | 409.76 Million |
| Capital Expenditure | -835.61 Million | -509.68 Million | -519.46 Million | -73.37 Million | -364.68 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 294.31 Million | 211.93 Million | 461.66 Million | -6.32 Million | 149.09 Million |
| Free Cash Flow | -597.43 Million | 303.04 Million | -57.27 Million | 51.51 Million | -172.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22 Million | -4 Million | 50 Million | 192.64 Million | 26 Million | 53 Million |
| Depreciation & Amortization | - | - | - | 86.28 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 147.32 Million | - | - |
| Other non-cash items | -22 Million | 4 Million | -50 Million | -150.59 Million | -26 Million | -53 Million |
| Investing Cash Flow | - | - | - | -836.32 Million | - | - |
| Investments in PPE | - | - | - | -835.61 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -1.2 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 486 Thousand | - | - |
| Financing Cash Flow | - | - | - | 892.45 Million | - | - |
| Debt repayment | - | - | - | -920.45 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -27.99 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -1000.00 | - | - |
| Accounts receivables | - | - | - | -83 Million | - | - |
| Accounts payables | - | - | - | 33.34 Million | - | - |
| Inventory | - | - | - | 175.41 Million | - | - |
| Other working capital | - | - | - | -150 Million | - | - |
| Cash at beginning of period | - | - | - | 1.07 Billion | - | - |
| Cash at end of period | - | - | - | 1.37 Billion | - | - |
| Capital Expenditure | - | - | - | -835.61 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | 294.31 Million | - | - |
| Free Cash Flow | - | - | - | -597.43 Million | - | - |
MET
9639
BSK
CRS
PMHG
4540